The immunopathogenesis of sepsis
暂无分享,去创建一个
[1] F. Gruber,et al. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage , 2002, Nature.
[2] John D. Fraser,et al. The Bacterial Superantigen Streptococcal Mitogenic Exotoxin Z Is the Major Immunoactive Agent of Streptococcus pyogenes1 , 2002, The Journal of Immunology.
[3] D. Annane,et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. , 2002, JAMA.
[4] John Land,et al. Association between mitochondrial dysfunction and severity and outcome of septic shock , 2002, The Lancet.
[5] S. Akira,et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution , 2002, Nature Immunology.
[6] W. Ruf,et al. Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.
[7] Kathy L. Frees,et al. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. , 2002, Archives of internal medicine.
[8] M. Vatn,et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study , 2002, The Lancet.
[9] A. Mantovani,et al. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. , 2002, Blood.
[10] M. Rämet,et al. Functional genomic analysis of phagocytosis and identification of a Drosophila receptor for E. coli , 2002, Nature.
[11] M. Belvin,et al. The Drosophila immune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein , 2002, Nature.
[12] P. Detmers,et al. Toll Receptors: a Central Element in Innate Immune Responses , 2002, Infection and Immunity.
[13] K. Anderson,et al. Requirement for a Peptidoglycan Recognition Protein (PGRP) in Relish Activation and Antibacterial Immune Responses in Drosophila , 2002, Science.
[14] S. Opal,et al. Bench-to-bedside review: Toll-like receptors and their role in septic shock , 2002, Critical care.
[15] Y. Ogura,et al. Nods: a family of cytosolic proteins that regulate the host response to pathogens. , 2002, Current opinion in microbiology.
[16] Corinne Alberti,et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study , 2002, Intensive Care Medicine.
[17] T. Michel,et al. Drosophila Toll is activated by Gram-positive bacteria through a circulating peptidoglycan recognition protein , 2001, Nature.
[18] K. Okajima. Regulation of inflammatory responses by natural anticoagulants , 2001, Immunological reviews.
[19] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[20] E. Ivers,et al. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .
[21] A. Norrby-Teglund,et al. Evidence for superantigen involvement in severe group a streptococcal tissue infections. , 2001, The Journal of infectious diseases.
[22] D. Landry,et al. The pathogenesis of vasodilatory shock. , 2001, The New England journal of medicine.
[23] C. Esmon,et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. , 2001, The New England journal of medicine.
[24] S. Akira,et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[25] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[26] J. Cavaillon,et al. Pyrogenicity and Cytokine-Inducing Properties ofStreptococcus pyogenes Superantigens: Comparative Study of Streptococcal Mitogenic Exotoxin Z and Pyrogenic Exotoxin A , 2001, Infection and Immunity.
[27] R. Hotchkiss,et al. Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans1 , 2001, The Journal of Immunology.
[28] M. Colonna,et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock , 2001, Nature.
[29] S. Akira,et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 , 2001, Nature.
[30] K. Tracey,et al. HMG‐1 REDISCOVERED AS A CYTOKINE , 2001, Shock.
[31] J Ean,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.
[32] M. Dinges,et al. Role of T Cells and Gamma Interferon during Induction of Hypersensitivity to Lipopolysaccharide by Toxic Shock Syndrome Toxin 1 in Mice , 2001, Infection and Immunity.
[33] T. Hartung,et al. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. , 2001 .
[34] F. Stüber. Effects of genomic polymorphisms on the course of sepsis: is there a concept for gene therapy? , 2001, Journal of the American Society of Nephrology : JASN.
[35] Y. Ogura,et al. Human Nod1 Confers Responsiveness to Bacterial Lipopolysaccharides* , 2001, The Journal of Biological Chemistry.
[36] K. Murthy,et al. Flagellin, a Novel Mediator of Salmonella-Induced Epithelial Activation and Systemic Inflammation: IκBα Degradation, Induction of Nitric Oxide Synthase, Induction of Proinflammatory Mediators, and Cardiovascular Dysfunction1 , 2001, The Journal of Immunology.
[37] A. Aderem,et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[38] D. Hultmark,et al. A family of peptidoglycan recognition proteins in the fruit fly Drosophila melanogaster. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Mira,et al. A Novel Polymorphism in the Toll-Like Receptor 2 Gene and Its Potential Association with Staphylococcal Infection , 2000, Infection and Immunity.
[40] A. Aderem,et al. Toll-like receptors in the induction of the innate immune response , 2000, Nature.
[41] K. Acharya,et al. Microbial superantigens: from structure to function. , 2000, Trends in microbiology.
[42] S. Foster,et al. Peptidoglycan and Lipoteichoic Acid from Staphylococcus aureus Induce Tumor Necrosis Factor Alpha, Interleukin 6 (IL-6), and IL-10 Production in Both T Cells and Monocytes in a Human Whole Blood Model , 2000, Infection and Immunity.
[43] M. Colonna,et al. Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes1 , 2000, The Journal of Immunology.
[44] K. Fukase,et al. Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity. , 2000, European journal of biochemistry.
[45] A. Bowie,et al. The interleukin‐1 receptor/Toll‐like receptor superfamily: signal generators for pro‐inflammatory interleukins and microbial products , 2000, Journal of leukocyte biology.
[46] R. Bucala,et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor , 2000, Nature Medicine.
[47] S. Korsmeyer,et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[48] T. van der Poll,et al. Pathogenesis of DIC in Sepsis , 1999 .
[49] S. Akira,et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.
[50] T. van der Poll,et al. Disseminated Intravascular Coagulation , 1999, Thrombosis and Haemostasis.
[51] K. Tracey,et al. HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.
[52] R. Hotchkiss,et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. , 1999, Critical care medicine.
[53] Yoshinori Nagai,et al. MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.
[54] H. Langen,et al. Digestion of Streptococcus pneumoniae Cell Walls with Its Major Peptidoglycan Hydrolase Releases Branched Stem Peptides Carrying Proinflammatory Activity* , 1999, The Journal of Biological Chemistry.
[55] R. Sékaly,et al. Understanding the mechanism of action of bacterial superantigens from a decade of research , 1999, Immunological reviews.
[56] A. Satoskar,et al. Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis , 1999, The Journal of experimental medicine.
[57] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[58] C. Janeway,et al. Introduction: the role of innate immunity in the adaptive immune response , 1998, Seminars in immunology.
[59] R. Bucala,et al. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[60] A. Devitt,et al. Human CD14 mediates recognition and phagocytosis of apoptotic cells , 1998, Nature.
[61] L. Björck,et al. Activation of the contact-phase system on bacterial surfaces—a clue to serious complications in infectious diseases , 1998, Nature Medicine.
[62] C. Dinarello,et al. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. , 1997, Chest.
[63] C. Janeway,et al. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.
[64] K. Asadullah,et al. Monocyte deactivation in septic patients: Restoration by IFN-γ treatment , 1997, Nature Medicine.
[65] K. Heeg,et al. Bacterial DNA causes septic shock , 1997, Nature.
[66] E. Hailman,et al. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. , 1997, The Journal of clinical investigation.
[67] R. Ulevitch,et al. Antibodies against CD14 protect primates from endotoxin-induced shock. , 1996, The Journal of clinical investigation.
[68] J. Bernhagen,et al. MIF as a glucocorticoid-induced modulator of cytokine production , 1995, Nature.
[69] R. Landmann,et al. Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. , 1995, The Journal of infectious diseases.
[70] A. Tomasz,et al. CD14 is a pattern recognition receptor. , 1994, Immunity.
[71] R. Ulevitch,et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.
[72] B. Bistrian,et al. Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.
[73] R. Dziarski,et al. Peptidoglycan Recognition Proteins A NOVEL FAMILY OF FOUR HUMAN INNATE IMMUNITY PATTERN RECOGNITION MOLECULES* , 2001 .
[74] J. Cohen,et al. Adjunctive therapy in sepsis: a critical analysis of the clinical trial programme. , 1999, British medical bulletin.
[75] M. Kotb,et al. Bacterial pyrogenic exotoxins as superantigens , 1995, Clinical microbiology reviews.